North Haven, CT, United States of America

Zoltan F Kanyo

This inventor holds 19 USPTO granted patents and 14 published patent applications and 4 EPO patents, primarily in Antimicrobial Compounds. Top assignees: Bioversys Ag, Melinta Therapeutics, Inc., Rib-X Pharmaceuticals, Inc.. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zoltan F Kanyo. Retrieved from https://idiyas.com/inventor/zoltan-f-kanyo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 14)

% Patents Active = 68.4

EPO Patents = 4 (Patent Applications = 13)

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 46(Granted Patents)

Location History:

New Haven, CT (US) (2018)
North Haven, CT (US) (2012 - 2024)

Company Filing History:

Melinta Therapeutics, Inc.

patents

3 out of 17

Rib-X Pharmaceuticals, Inc.

patents

Years Active: 2012-2025

Loading Chart...

Areas of Expertise:

Antimicrobial Compounds

Pyrrolo[2,3-d]pyrimidines

Biodefense Agents

Triazole Compounds

Macrocyclic Compounds

Drug Development

Pharmaceutical Chemistry

Compound Synthesis

Antimicrobial Methods

Infectious Disease

Chemical Formulations

Novel Antibiotics

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12297201 - Substituted pyrrolo[2,3-d]pyrimidines as antimicrobials (2025-05-13),

2. 12234238 - Antimicrobial compounds and methods of making and using the same (2025-02-25),

3. 12152031 - Biodefense agents (2024-11-26),

4. 11999739 - Antimicrobials methods of making and using the same (2024-06-04),

5. 11098047 - Antimicrobials and methods of making and using same (2021-08-24),

6. 10947237 - Antimicrobial compounds and methods of making and using the same (2021-03-16),

7. 10934295 - Antimicrobials and methods of making and using same (2021-03-02),

8. 10815238 - Antimicrobial compounds and methods of making and using the same (2020-10-27),

9. 10815237 - Antimicrobials and methods of making and using same (2020-10-27),

10. 10106543 - Antimicrobial compounds and methods of making and using the same (2018-10-23),

11. 9937183 - Antimicrobial compounds and methods of making and using the same (2018-04-10),

12. 9221827 - Antimicrobial compounds and methods of making and using the same (2015-12-29),

13. 9193731 - Antimicrobial compounds and methods of making and using the same (2015-11-24),

14. 9085600 - Triazole compounds and methods of making and using the same (2015-07-21),

15. 9006189 - Triazole compounds and methods of making and using the same (2015-04-14),

Hello! I'm excited to share an article with you about inventor Zoltan F Kanyo from North Haven, CT, US, known for his remarkable contributions in the field of antimicrobial compounds. Let's delve into his impressive journey.

**Title: Unveiling the Genius of Zoltan F Kanyo: Pioneer in Antimicrobial Compounds**

Introduction

Zoltan F Kanyo, a prolific inventor hailing from North Haven, CT, has established himself as a leading figure in the realm of antimicrobial compounds, with a total of 15 patents to his name.

Latest Patents

Among his recent patents is the groundbreaking invention titled "Antimicrobials and methods of making and using same". This revolutionary disclosure focuses on antimicrobial compounds and their applications in treating and preventing microbial infections in both humans and animals.

Career Highlights

Throughout his career, Kanyo has showcased his expertise in companies such as Melinta Therapeutics, Inc. and Bioversys Ag, where he has honed his skills and advanced the field of antimicrobial research.

Collaborations

In his professional journey, Kanyo has collaborated with esteemed individuals such as Ashoke Bhattacharjee and Erin M Duffy, whose combined efforts have propelled the development of innovative solutions in combating microbial infections.

Conclusion

In conclusion, Zoltan F Kanyo's dedication to pioneering antimicrobial compounds has significantly contributed to the advancement of healthcare, offering new possibilities in the treatment and prevention of microbial infections. His work stands as a testament to innovation and excellence in the field.

Profile summary based on public USPTO records.